TLR4 agonist preparation - MPLA-SM
MPLA-SM* | Unit size | Cat. code | Docs | Qty | Price |
---|---|---|---|---|---|
Monophosphoryl Lipid A from S. minnesota R595 |
1 mg |
tlrl-mpla2 |
You may also need : CRX-527 | View more associated products ▼
Notification: MPLA-SM* is a new preparation of MPLA-SM (now removed from our catalog) which is more potent at inducing human TLR4 responses.
Monophosphoryl Lipid A from Salmonella minnesota R595
InvivoGen provides two preparations of Monophosphoryl Lipid A extracted from the lipopolysaccharide (LPS) of Salmonella minnesota Re595 (Re mutant), a rough strain of Gram-negative bacteria, for Toll-like receptor 4 (TLR4) activation:
MPLA-SM* and MPLA-SM are extracted from LPS using treatment with acid and heat followed by chromatography [1]. These preparations contain a mix of MPLA congeneric forms differing in the number of acyl chains. It has been suggested that this mix is responsible for the partial TLR4 agonist function of some preparations [2]. MPLA-SM* is a new reference in our catalog. It results from an improved process of MPLA-SM extraction. While MPLA-SM* and MPLA-SM have the same ability to activate murine TLR4, MPLA-SM* is more potent than MPLA-SM at inducing human TLR4 responses (see figures).
Key features:
- Agonists of mouse and human TLR4
- Negligible TLR2 activity
-
Each lot is functionally tested
Note: MPLA-SM* is also available in pre-clinical grade as MPLA-SM* Vaccigrade™.
References:
1. Qureshi N. et al., 1985. Monophosphoryl lipid A obtained from lipopolysaccharides of Salmonella minnesota R595. Purification of the dimethyl derivative by high-performance liquid chromatography and complete structural determination. J. Biol. Chem. 260, 5271–8.
2. Wang YQ. et al., 2020. MPL Adjuvant Contains Competitive Antagonists of Human TLR4. Front. Immunol. 11:577823.
Specifications
Species: Salmonella enterica serovar minnesota mutant R595
Specificity: TLR4 agonist
Working concentration: 3 ng - 1 μg/ml (for human TLR4) and 10 pg - 1 µg/ml (for mouse TLR4)
Appearance: Clear lipidic film
Solubility: 1 mg/ml in DMSO
Quality control:
- Biological activity has been tested using HEK-Blue™ hTLR4 cells.
- The presence of other bacterial components (e.g. lipoproteins) is controlled using HEK-Blue™ TLR2 cells.
Back to the top
Contents
MPLA-SM* is provided as a clear, lyophilized lipidic film.
- 1 mg Monophosphoryl Lipid A (MPLA-SM*)
The product is shipped at room temperature.
Store at -20°C. Upon resuspension, prepare aliquots and store them at -20°C.
The product is stable for 6 months at -20°C.
Avoid repeated freeze-thaw cycles